Indictment Casts Doubt On Results In AID Malaria Project

WASHINGTON—The focus of the troubled 15-year U.S. Agency for International Development program to develop a malaria vaccine (The Scientist, July 10, 1989, page 1) has moved from the laboratory to the courtroom as government investigators charge that an attempt to halt a Third World plague may have been used by some scientists as a source of personal gain. One of the leading scientists in the research program has been indicted on felony charges, and at least two other technical invest

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WASHINGTON—The focus of the troubled 15-year U.S. Agency for International Development program to develop a malaria vaccine (The Scientist, July 10, 1989, page 1) has moved from the laboratory to the courtroom as government investigators charge that an attempt to halt a Third World plague may have been used by some scientists as a source of personal gain.

One of the leading scientists in the research program has been indicted on felony charges, and at least two other technical investigators plus a former manager of the program are targets of further probes. Moreover, charges of financial mismanagement and incompetence have led some researchers to question the scientific merits of the search for a cheap and universal vaccine against malaria. Two scientists have told The Scientist that they now believe earlier test results are suspect, and that so-called breakthroughs have produced results that could not be duplicated by other labs.

The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jim Anderson

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours